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IN MALES, ANDROGENS ARE ESSENTIAL for puberty, fertility, sexual motivation, and sexual performance (16) . Testosterone production is predominantly regulated through interaction of luteinizing hormone (LH)/human chorionic gonadotropin (hCG) with its specific receptor (6, 11) , resulting in increased intracellular cAMP level and subsequent activation of cAMPdependent protein kinase (PKA). PKA phosphorylates numerous proteins including those that facilitates cholesterol transport across mitochondrial membranes such as translocator protein (TSPO) and steroidogenic acute regulatory protein (StAR) delivering substrate to steroidogenic enzyme machinery (7, 21, 39) . Further biosynthesis from cholesterol to testosterone include activities several steroidogenic enzymes: cytochrome P450 side-chain cleavage enzyme (CYP11a), hydroxysteroid dehydrogenase (HSD)-3b, 17a-hydroxylase/C17-20lyase (CYP17a), and HSD-17b (25) . Although Leydig cell steroidogenesis is dominantly regulated by cAMP-PKA signaling several other pathways also contribute to this process (28, 36) , including the cGMP signaling pathway (1, 13, 38) . The NOS-GUCY1 signaling pathway was found in Leydig cells (1, 2, 8, 20) and its activation modulates testicular androgenesis in accord with systemic hormones and locally produced NO and cGMP (1, 2, 13, 20) . At higher concentrations, locally produced NO directly inhibits steroidogenic enzymes (9, 10, 26) and at lower concentrations stimulates cGMP production and activates protein kinase G1 (PKG1) causing phosphorylation of StAR protein (1, 13) as well as other target proteins (32) . The intracellular level of cGMP is controlled by cGMP-selective phosphodiesterases (PDEs), expressed in Leydig cells (1, 2, 20, 33) and inhibition of Leydig cell PDE5 in vitro, were accompanied by elevations of cGMP and testosterone production (1) . Additionally, in mice, chronic inhibition PDE5 caused ultrastructural changes characteristic for secretory active Leydig cells (31) .
In the past two decades, PDE5 became a target for drug development for a variety of physiological disorders, and in 1998 sildenafil was the first PDE5-specific inhibitor approved for the treatment of erectile dysfunction (3) . There is a report that more than 20 million men worldwide are treated with this drug (35) . Recently, several clinical research studies of pulmonary hypertension, using high dosages of sildenafil for long time as additional therapy, proved to be beneficial in the management of the disease (39) . Therefore, it could be of interest to explore the potential effects of the most frequently used drug in the treatment of erectile dysfunction, Viagra, on testosterone secretion by Leydig cells as well as on the NOSdependent signaling cascade in Leydig cells.
This study was designed to evaluate the effects of prolonged in vivo inhibition of PDE5 on Leydig cell steroidogenesis by following the expression/function of steroidogenic machinery, as well as NO-cGMP signaling. Additionally, the relationships between cAMP-and cGMP-signaling in the regulation of Leydig cell steroidogenesis were studied. Our results indicate that prolonged in vivo PDE5 inhibition stimulates androgen production, mostly via activation of cAMP/cGMP signaling and consequent activation of StAR protein.
MATERIALS AND METHODS

Materials.
The antisera for StAR protein were generous gifts from Profs. Douglas Stocco (7) and Dale B. Hales (15) , while the purified rabbit polyclonal antibody against PDE5 was a generous gift from Prof. Sergei Rybalkin (28) . Commercial antibodies and all other reagents are listed in detail and given as supplemental material (Supplemental material can be found in the online version of this paper at the Journal website). Sildenafil (Viagra) in tablets was from Pfizer (www.Pfizer.com).
Ethical approval. Animals and treatment. Adult (3 mo old, 250 -270 g body wt) male Wistar rats, bred and raised in the Animal Facility of the Faculty of Sciences (University of Novi Sad), were used for the experiments. The animals were raised in controlled environmental conditions (22 Ϯ 2°C, 12:12-h light-dark cycle, lights on at 0700) with food and water ad libitum. Animals were divided into two groups, each consisting of eight adult male rats: 1) Control group, received pure distilled water daily for 30days and 2) sildenafil-treated group, received sildenafil (Viagra; www.Pfizer.com) dissolved in distilled water by oral dosing (1.25 mg/kg body wt) daily for 30 days. Experiments were repeated at least three times. At the end of the experimental period, both groups were quickly decapitated, serum was collected, serum samples were stored at Ϫ20°C until assaying for androgens (TϩDHT) levels, and ex vivo experiments were performed.
The methodology for the studies included in this article is briefly outlined here, but it was previously reported by our group (1, 2, 19, 20) and is given with all details in the supplemental material.
Preparation of leydig cells and ex vivo androgens, NO, and cAMP/cGMP production. To follow ex vivo steroidogenic function, we used Leydig cells obtained from control and sildenafil-treated rats. Primary cultures of purified Leydig cells were prepared from suspensions of interstitial cells, as previously described by our group (1, 2, 19, 20) . The proportion of Leydig cells present in culture was determined by staining for HSD-3b activity (24) and was found to be 97.9 Ϯ 1.4%, while the viability was more than 90%. (1, 2, 19, 20) . Purified Leydig cells obtained individually from eight rats were pooled and plated in Petri dishes (3 ϫ 10 6 cells/3 ml culture medium per dish). Three to five replicates of each pool/group were cultured for ex vivo secretion and expression analysis. After 2 h, cell-free medium was collected and stored at Ϫ80°C prior to the measurement of androgens levels, while cAMP and cGMP were measured in cell content. For the expression analysis of transcripts/proteins, Leydig cell lysates were used as a source of RNA/protein.
Androgens, NO, and cAMP/cGMP measurement. Androgens levels were measured by radioimmunoassay (1, 2, 19, 20) . Levels of androgens are referred to as testosterone ϩ dihydrotestosterone (TϩDHT) because the anti-testosterone serum no. 250 showed 100% crossreactivity with DHT. All samples were measured in duplicate in one assay (sensitivity: 6 pg per tube; intra-assay coefficient of variation 5-8%). For measurement of nitrite (stabile metabolic product of NO) levels in the medium, sample aliquots were mixed with an equal volume of Griess reagent, and absorbance was measured at 546 nm (14) . Nitrite concentrations were determined relative to a standard curve derived from increasing concentrations of sodium nitrite (1, 2, 20). The cAMP and cGMP were extracted from scraped cells content by ethanol, using a procedure described previously (18) . The level of cAMP in cell content of scraped purified Leydig cells was measured with a cAMP EIA kit that permits cAMP measurement with a limit of quantification of 0.1 pmol/ml (at 80% B/B0) and an IC50 of ϳ0.5 pmol/ml for acetylated cAMP samples (19) . The level of cGMP was measured with a cGMP EIA kit that permits cGMP measurement typically with the limit of quantification of 0.07 pmol/ml (at 80% B/B 0) for acetylated cGMP samples (1, 2, 20) .
RNA isolation and cDNA synthesis. Total RNA from purified rat Leydig cells was isolated using an RNeasy kit following a protocol recommended by the manufacturer (www.qiagen.com). To eliminate residual genomic DNA, RNA samples were treated with DNase I, and first-strand cDNA was synthesized with a Superscript III reverse transcriptase kit according to the manufacturer's instructions (www. invitrogen.com) (1, 2, 19, 20) .
Real-time polymerase chain reaction and relative quantification. The relative expression of the genes was quantitated by real-time polymerase chain reaction (PCR), and two types of chemistries were used to detect PCR products: SYBR Green-based and TLDA (TaqMan Low Density)-based detection in an ABI Prism 7900HT Sequence Detection System (www.appliedbiosystems.com).
SYBR green. The relative expression of the genes by use of SYBR Green for amplicon detection was done as previously described (2, 4, 20) . Standard PCR settings were used in the presence of specific primers designed by using softver Primer Express 3.0 (Applied Biosystems) and full gene seqences from NCBI Entrez Nucleotide database (www.ncbi.nlm.nih.gov/sites/entrez). The primer sequences used for real-time PCR analysis are given in Table 1 (for steroidogenic machinery components and Actb) and in Table 2 (for NO-cGMP signaling elements) in the supplemental matherial. Relative quantification of each gene was done in duplicate, twice for each of three independent in vivo experiments. The relative quantification of gene expression was calculated using ABI 7900HT SDS and RQ Manager Software.
TLDA Rat Phosphodiesterase Panel Assay. The expressions of the genes for PDEs in Leydig cells obtained from control and experimental rats were analyzed in relative quantification real-time PCR by using the TLDA Rat Phosphodiesterase Panel Assay as described previously (20) . Each sample was done in duplicate or triplicate, three times for each gene, for each of three independent in vivo experiments.
Protein extraction and western blot analysis. After incubation, Leydig cells (3 ϫ 10 6 /well) were lysed as described previously (1, 2, 19, 20) . Immunodetection of the StAR protein was performed using the antisera for StAR protein (dilution 1:500; 7, 15). The level of NOS2 was detected by purified anti-mouse antibody against NOS2 (dilution 1:1,000), while GUCY1 subunits were immunodetected with purified rabbit polyclonal antibodies against a1 or b1 subunits of GUCY1 (dilution 1:1,000). PKG1 was detected using rabbit polyclonal antibody recognizing type a/b isoforms of PKG1, while PDE5 was detected with rabbit polyclonal antibody against PDE5 [dilution 1:500 (26); 1: 1,000, commercial]. Actin was detected using an actin detection kit (dilution 1:5,000). The immunoreactive bands were analyzed as two-dimensional images using the Image J (version 1.32; www.rsb.info.nih.gov/ij/download.html). The optical density (OD) of images is expressed as volume (OD ϫ area) adjusted for the background, which gives arbitrary units of adjusted volume.
Statistical analysis. For in vivo studies, the results represent group means Ϯ SE of individual variation from three independent experiments (8 rats per group per experiment). For ex vivo measurement, data represent means Ϯ SE from three to five independent replicates. The results from each experiment were analyzed by Mann-Whitney's unpaired nonparametric two-tailed test (for two-point data experiments) or, for group comparison, a one-way ANOVA followed by the Student-Newman-Keuls multiple range test.
RESULTS
Effects of prolonged treatment with sildenafil on testosterone, cAMP/cGMP, and nitrite production by Leydig cells.
In adult male rate, sildenafil treatment for 30 days caused a moderate but significant increase in serum TϩDHT levels (Fig. 1A) . Purified Leydig cells derived from sildenafil-treated rats had increased basal testosterone production (Fig. 1B ) and higher cAMP level (Fig. 1C) . On the other hand, basal NO production by purified Leydig cells from sildenafil-treated animals was decreased (Fig. 1D) following by unchanged cGMP levels (Fig. 1E) .
Modulation of Leydig cells steroidogenic activity in sildenafil-treated rats. To investigate the effects of prolonged PDE5 inhibition on Leydig cell steroidogenic capacity, cells were challenged with increasing concentrations of hCG. Leydig cells derived from sildenafil-treated rats exhibited a greater response upon hCG stimulation. This was illustrated by an enhanced dose-dependent increase of testosterone production ( Fig. 2A ) and cAMP accumulation (Fig. 2B) . The expression of specific elements of steroidogenic machinery was analyzed by extracting mRNA from purified Leydig cells obtained from controls and sildenafil-treated male rats. RQ-PCR analysis revealed that LH receptor (Lhr), steroidogenic factor 1 (Sf1), scavenger receptor class B type 1 (Scarb1), Tspo, Star, Cyp11a, Hsd3b, Hsd17b, aromatase (Cyp19), androgen receptor (Ar), and estrogen receptor 1␣ (Esra1) expressions were unaffected after 30 days of PDE5 inhibition, while only Cyp17 expression was increased (Fig. 2C) . Considering the importance of cyclic nucleotides, especially cAMP, in initiation of testosterone synthesis, it was of interest to analyze the PDE expression in the same samples. For that purpose we applied the commercial TLDA Rat Phosphodiesterase Gene Signature Panel. Results showed that expression of Pde4a, which specifically degrades cAMP in Leydig cells, were decreased by sildenafil treatment, whereas other cAMP-specific PDEs, Pde4b, Pde4d, Pde7a, Pde7b, Pde8a and Pde8b, remained unchanged (Fig. 2D) .
NO-cGMP signaling pathway in Leydig cells from sildenafil-treated rats. The expression of specific components of NO-cGMP signaling pathway was analyzed by extracting mRNA from purified Leydig cells obtained from controls and sildenafil-treated male rats. Gene and protein expression levels were accessed by RQ-PCR and Western blot, respectively.
Results of real-time PCR analysis revealed that Nos2 expression was decreased in sildenafil treatments, whereas Nos3 was not significantly changed (Fig. 3A) . The Nos1 transcript was below detectable level (C T Ͼ 30 cycles), so it was omitted from the present work. Additionally, sildenafil treatment increased expression of Gucy1a1 as well as Gucy1b1 subunits, whereas Pkg1 and Pde5 were not affected (Fig. 3A) . TLDA showed that mRNA of Pde6c highly selective for cGMP hydrolysis was decreased by sildenafil treatment, whereas Pde6d and Pde9a were not affected (Fig. 3F) . Additionally, regarding PDEs with dual substrate affinity, Pde1a was decreased (Fig. 3G) in the presence of unchanged mRNA expression of Pde1c, Pde2a, Pde3a, Pde3b, and Pde10a (Fig. 3G) .
Western blot analysis confirmed an inhibitory effect sildenafil treatment on NOS2 expression (Fig. 3B ) and a stimulatory effect on GUCY1 (Fig. 3C ). In the same samples, levels of PDE5 (Fig. 3D) as well as PKG1 (Fig. 3E ) protein levels were unaffected.
Coordinative actions of cAMP/cGMP on StAR activation in Leydig cells from sildenafil treated rats.
To study the functional significance of sildenafil-increased GUCY1 expression, Leydig cells derived from sildenafil-treated and control rats were incubated with increasing concentrations of NO donor (DPTA). Since it is well established that NO in higher concentrations directly suppresses Leydig cells in vitro by inhibition of heme-containing steroidogenic enzymes (9, 10, 26), to 6 /well) were incubated for 2 h, and testosterone (B) as well as nitrite (D) accumulation were determined in incubation medium. Cells were scraped, and cyclic nucleotides extracted by ethanol and cAMP (C) as well as cGMP (E) levels were determined by RIA. Data bars are group means Ϯ SE of 3 independent experiments. Statistical significance between controls and experimental groups: *P Ͻ 0.05. 6 /well) were incubated in the presence of increasing concentration of hCG (0, 0.5, 5 and 50 ng/ml) for 2 h and testosterone accumulation was measured in incubation medium. B: cells were scraped and used for cAMP extraction and levels determination. C: quantitative gene expression of steroidogenic elements in Leydig cells derived from sildenafil-treated and control rats were followed by RQ-PCR using specific primers. D: quantitative gene expression of cAMP specific Pdes was performed by TaqMan Low Density Rat Phosphodiesterase Panel. Data bars are group means Ϯ SE of 3 independent experiments. Statistical significance between controls and sildenafil treated groups: *P Ͻ 0.05. reduce the direct inhibitory effect of NO on hormone production, cells were exposed in a dose range to 10 M DPTA. Such a treatment led to a concentration-dependent increase in cGMP production, which was higher in Leydig cells derived from sildenafil-treated rats (Fig. 4B) . The androgen production followed the cGMP pattern (Fig. 4A) . In the same samples, sildenafil treatment caused greater accumulation of intracellular cAMP independently of NO stimulation (Fig. 4C) . These data taken together, in a stimulatory dose range of DPTA, testosterone correlates much more strongly with cGMP (R ϭ 0.983, P Ͻ 0.05) than with cAMP (R ϭ 0.693, not significant). Furthermore, DPTA dose-dependently stimulated testosterone production even in cells stimulated with supramaximal hCG (50 ng/ml), and this effect was augmented in cells obtained from sildenafil-treated rats (Fig. 4D) . It looks like hCG-supported elevation of cAMP (Fig. 4F) has an additive effect with NO-induced elevation of cGMP (Fig. 4E ) in the regulation of testosterone production (Fig. 4D) . Since sildenafil treatment increased intracellular NO-induced cGMP as well as hCGstimulated cAMP accumulation, it was reasonable to analyze activation of StAR protein in Leydig cells. Western blot analysis showed that elevation of both cGMP and cAMP intracellular levels led to increased formation of mature StAR protein in Leydig cells obtained from sildenafil-treated rats compared with control (Fig. 4G) . Moreover, simultaneous activation of both signaling pathways additionally increased the level of StAR protein (Fig. 4G ) and consequently stimulate testosterone production (Fig. 4D) .
DISCUSSION
Results from this study have shown that prolonged PDE5 inhibition in vivo stimulated Leydig cells steroidogenesis and increased circulating level of testosterone due to coordinative stimulatory effect of cAMP and cGMP action. Two lines of evidence indicated that prolonged PDE5 inhibition changed the Fig. 4 . Sildenafil treatment increased NO-induced GUCY1 activity and stimulated testosterone production. Primary cultures of Leydig cells (3 ϫ 10 6 /well) were incubated in presence of increasing DPTA concentrations (0, 1, 5, and 10 M) with or without hCG (50 ng/ml) for 2 h, and testosterone accumulation was determined in incubation medium (A and D). Cells were used for cyclic nucleotide extraction and cGMP (B and E) and cAMP (C and F) determination. Western blot analysis for StAR protein following hCG (10 ng/ml) and DPTA (1 M) stimulation (G). Data are means Ϯ SE of 3 independent experiments performed in duplicates. Statistical significance at level P Ͻ 0.05: * vs. corresponding control group; # vs. corresponding untreated/basal cells. expression/activity pattern of both cAMP and cGMP signaling pathway elements. First, in the Leydig cells obtained from sildenafil-treated rats, the intracellular cAMP level was increased due to inhibition of Pde4a expression. Second, prolonged sildenafil treatment disturbed NO-cGMP signaling in Leydig cells via inhibition of NOS2 and stimulation of GUCY1 expression. Finally, both signaling pathways converged on StAR protein, stimulating the first step in steroidogenesis to enhance testosterone production.
It is well known that Leydig cell androgenesis depends on a rise at the intracellular level of cyclic nucleotides, especially cAMP, and that its fate, once synthesized, is controlled by catabolic enzymes (36) . Results from our study show that adult rat Leydig cells express transcripts for several cAMP-specific Pdes such are Pde4a, Pde4b, Pde4d, Pde7a, Pde7b, Pde8a, and Pde8b, presumably most of them contributing to Leydig cell response to LHR-cAMP signaling. Decreased expression of Pde4a in Leydig cells obtained from sildenafil-treated rats and consequent increased cAMP accumulation indicates its participation in the control of the relevant cAMP pool(s). Moreover, augmented stimulation of cAMP production in response to hCG stimulation was observed in Leydig cells derived from sildenafil-treated rats. Increased cAMP accumulation could act on PKA to coordinately increase the transcription of genes required for steroid hormone biosynthesis, including StAR protein, Cyp11a1, and Cyp17a1 (22, 37) . Our results showed enhanced Cyp17a1 expression in Leydig cells isolated from sildenafil-treated rats, while the expression for StAR and Cyp11a1 remained unchanged. At present, it is difficult to explain such selective stimulation, since multiple transcription factors, including SF-1, GATA-6, and sterolregulatory binding protein-1, can be recruited to the promoter during activated Cyp17a1 transcription (34, 37) . Although expression of mRNA transcripts for StAR protein was not significantly changed, sildenafil treatment increased the level of mature StAR protein, which was further potentiated in hCG-supported steroidogenesis. At present time, it is difficult to explain the discrepancy observed between the mRNA and protein levels due to the complex mechanisms governing STAR mRNA levels, which include the evidence that some aspects of regulation of STAR expression may occur at the posttranscriptional level (27) . Since the StAR protein mediates the rate-limiting step in steroidogenesis, its expression must be finely regulated for its primary expression in steroidogenic cells. Furthermore, StAR gene expression must be able to respond rapidly to various signals that regulate steroidogenesis. Most likely combinatorial events regulate StAR transcription and may affect StAR transcription at different levels. Although the regulation of the StAR gene has been the focus of intense study, the precise mechanism of StAR gene activation remains to be determined, and regulation of the StAR gene appears to be a complex process involving a number of different transcription factors (27) . The importance of StAR protein for transport of cholesterol through mitochondrial membranes needed for initiation of steroidogenesis is well illustrated (36) . The rise at the intracellular level of cAMP activates phosphorylation of this protein by PKA and initiates the post-or cotranslational events responsible for the occurrence of a mature StAR form that increase its biological activity (7, 21) .
In addition to steroidogenic machinery, prolonged sildenafil treatment also affects NO-cGMP signaling in Leydig cells. Our results showed reduced NOS2 expression followed by declined NO production. In the same system, enhanced expression of GUCY1 was observed. In untreated Leydig cells basal GUCY1 activity is relatively low, and PDE5 has little impact under these conditions. In presence of the NO donor DPTA, the activity of GUCY1 was several time higher and was further potentiated by chronic PDE5 inhibition. Since NO from neighboring cells contributes to local regulation of testosterone production (40) , augmented GUCY1 could potentiate the paracrine effect of NO. Increased level of GUCY1 in Leydig cells derived from sildenafil-treated rats makes them more sensitive to NO stimulation in term of increased de novo synthesis of cGMP. It has been shown that in this signaling scenario cGMP activation of PKG1 promotes phosphorylation and consequent activation of StAR protein, leading to increased steroidogenesis (1, 13) . These findings helped to further progress in our understanding of molecular events in Leydig cells obtained from sildenafil-treated rats. In these cells, an increased level of mature StAR protein was observed after NO stimulation ex vivo. This was additionally potentiated with hCG-dependent elevation of cAMP. According to results from this study, it seems that both cGMP and cAMP signaling act synergistically and both converge on StAR protein to enhance testosterone production.
In the case of increased NO-dependent GUCY1 activity, decreased expression of cGMP-specific PDEs could be the mechanism that promotes a stimulatory effect of cGMP on Leydig cell steroidogenesis. Eight families of PDEs hydrolyze cGMP with different efficiencies. These eight families are separated into two groups: the cGMP-specific group and the dual-substrate specificity group. Our results indicate that adult rat Leydig cells express mRNA of Pde5a, Pde6c, Pde6d, and Pde9a from the first group. Sildenafil treatment significantly reduced Pde6c the mRNA level in Leydig cells without any effect on Pde5a expression. The reason for such selective inhibition of PDE expression could be compartmentalized cGMP hydrolytic regulation (12) ; so the inhibition of specific PDE may result in different targeted effects from those derived by cyclase activation. In addition, sildenafil is a most specific competitive inhibitor for PDE5, but, because of structural similarity of enzyme active site, it also inhibits the photoreceptor PDE6 in the nanomolar range of concentration (3) . From the second group of PDEs, with dual-substrate specificity, Leydig cells express Pde1a, Pde1c, Pde2a, Pde3a, Pde3b, and Pde10a. Among them, only Pde1a was inhibited by sildenafil treatment. Ca 2ϩ /calmodulin-stimulated PDE1 has been shown to be important for the regulation of cGMP level in vascular cells (29) . PDE1A1 enzyme activity, protein level, and mRNA expression are selectively upregulated in the nitrite-tolerant rat model (17) . Since Leydig cells obtained from sildenafil-treated rats produced lower amounts of NO, lowering PDE1A1 expression could be a consequence of decreased NO production.
The present results support the hypothesis of a dual stimulatory effect of cGMP-and cAMP-mediated signals in Leydig cells and suggests that the effects of PDE5 inhibitors in addition to changed NO-cGMP signaling may also include actions of the cAMP second messenger system. The exact mechanism by which such an interaction occurs is not clear, but it involves decreased expression of the cAMP-specific PDE4a by the inhibition of PDE5. This will, in turn, lead to increasing levels of cAMP, which promote the interaction of cAMP with PKA followed by activation of StAR protein and the steroidogenic cascade (36) . Increased GUCY1 capacity in Leydig cells from sildenafil-treated rats followed by enhanced NO-dependent activation of GUCY1 exhibited an additive effect with cAMP-dependent modification of StAR protein indicates the existence of two mechanisms focused on StAR protein to stimulate androgen production. Our results of decreased expression of cGMP-specific Pde6c and Pde1a with dual selectivity in addition to Pde4a in sildenafil-treated Leydig cells could be mechanism that promotes stimulatory effect of cyclic nucleotides on Leydig cells steroidogenesis.
In addition, it is noteworthy to speculate about the possible effects of sildenafil citrate on testicular blood flow and its possible effect on testicular steroidogenesis. Our preliminary unpublished results showed increased volume of testicular interstitial fluid and testosterone production following the acute, 2-h treatment with Viagra. This effect is most probably a consequence of increased blood flow following sildenafil treatment, and further studies in this subject are required.
Finally, the physiological significance of the results presented was suggested by the increased serum testosterone level following prolonged sildenafil treatment. A similar effect was reported with two different types of PDE5 inhibitors (sildenafil and tadalafil) applied to men who suffered from erectile dysfunction (5). In addition, it has been shown recently that frequent low-dose use of sildenafil and/or tadalafil combined with testosterone has a pronounced antiapoptotic effect on the cavernous tissues of diabetic rats (23) . Accordingly the importance of testosterone in maintaining erectile function is clinically manifested in disorders such as the metabolic syndrome, in which the hypogonadal state is frequently accompanied by erectile and sexual dysfunction.
